New Study Associates Behavior from Digital Cognitive Assessments with Key Biological Markers for Alzheimer’s Disease

Research Reinforces Linus Health’s Approach to Delivering Practical and Effective Assessments

Navignostics Selects Celegence's CAPTIS™ Technology Solution to Support IVDR Compliance

Celegence, a global provider of regulatory affairs services for the life sciences industry, is pleased to announce that Navignostics, a global developer of drug mechanisms designed to identify ideal treatments for cancer patients, has selected Celegence’s CAPTIS™ technology solution to support Performance Evaluation Reports and other PMS documentation in compliance with the In-Vitro Diagnostic Regulation (IVDR).

Ardena announces major expansion plans for Swedish site

The expansion will increase development and manufacturing for small molecules at the Södertälje facility with new equipment and increased capabilities to strengthen the firm’s existing expertise in drug substance manufacture.

New Consumer Research Underscores Self-Service Digital Patient Access as Essential for Healthcare Organizations

President Bill Clinton, Nikki Haley to Attend 2022 ITServe Synergy Conference in Orlando as Special Keynote Speakers

The 7th annual ITServe Synergy Conference will take place October 26-28 in Orlando, FL. Keynote speakers for this year's conference include President Bill Clinton, former South Carolina Governor and U.S. Ambassador to the United Nations Nikki Haley, and ISHA Foundation founder and yoga guru Sadhguru JV. Held annually since 2015 by the ITServe Alliance, the largest association of IT Solutions and Services organizations in the U.S., the Synergy conference offers CEOs and CXOs from technology, staffing, and services companies an opportunity to network and build new relationships to grow their businesses.

Recipharm strengthens pre-filled syringe and cartridge offering with new investment

END Contact information For media enquiries, please contact Imogen Quail, PR Manager, at ramarketing: imogen.quail@ramarketingpr.com, +44 (0)191 222 1242, ramarketingpr.com, Twitter: @ramarketingpr, Facebook: /ramarketingpr, LinkedIn: /ramarketing About Recipharm Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing almost 9,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and manufacturing of medical devices. Recipharm manufactures several hundred different products to customers ranging from big pharma to smaller research and development companies. The company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Stockholm, Sweden. For more information on Recipharm and our services, please visit www.recipharm.com 1Source Safety Prefilled Syringe Market Size is expected to reach (globenewswire.com) Recipharm AB Corporate identity number 556498-8425 Address Box 603, SE-101 32 Stockholm, Sweden, Telephone +46 8 602 52 00 www.recipharm.com

Biopharma PEG Provides Large Scale PEG Derivatives Applied In The Pharmaceutical Industry

CD BioSciences Launches Cell Death Solutions for Life Science Researchers

CD BioSciences recently announced the launch of a comprehensive panel of research solutions covering all aspects of cell death study.

Amerigo Scientific Launches New Polyclonal Antibody to Human Blood Coagulation Factor XIII

Amerigo Scientific recently announced the launch of its new polyclonal antibody to human blood coagulation factor XIII for the detection of blood coagulation factor XIII.

STEMart Launches Biological Indicator Sterility Testing Service for Medical Devices

STEMart has recently introduced Biological Indicator Sterility Testing services for the industry of medical devices.

Creative Diagnostics Introduces Fluorometric Neuraminidase Assay Service for High-throughput Discovery

Creative Diagnostics recently introduced Fluorometric Neuraminidase Assay services to the global research community.

CCS Selects ZeOmega’s Care Management Solution to Improve Outcomes for Diabetes Patients While Reducing Costs

Integration Identifies Members’ Needs, Helps Guide Home Healthcare Delivery

A Robust Telomere Aging Clocks Platform Helps Conduct Lab-Grade Telomere Length Analysis

A robust telomere aging clocks system combined with RF, qPCR, STELA, and TESLA techniques is newly reconfigured to conduct specialized lab-grade telomere length analysis and offer comprehensive pictures of biological aging.

CyncHealth to Showcase Successful Partnership at Lyniate Customer Conference Leading HIE Partners with Lyniate on Interoperability Suite to Power Regional Data Exchange

Form Bio Doubles Down on Growth Strategy; Hires Top Industry Exec to Fuel Sales and Customer Acquisition Mark Swendsen Appointed Chief Revenue Officer, Further Strengthening Veteran Leadership Team

Form Bio is a new, cutting-edge research and discovery platform for individuals and enterprises in life sciences. With the most accessible, comprehensive and collaborative platform in the field, Form Bio empowers scientists to efficiently and effectively harness the proliferation of data and computing power that has transformed the science of discovery. Form offers end-to-end integration of the discovery process with intuitive and easy-to-use software applications, combined with an open and adaptable collaborative environment. Form Bio was developed within Colossal Biosciences and co-founded by Ben Lamm, Andrew Busey, and Kent Wakeford. For more information on Form Bio, please visit www.formbio.com

Samsung Biologics obtains three global ISO certifications

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced today it has successfully renewed its ISO 27001 certification (Information Security Management System) and obtained ISO 27017 certification (Information Security in cloud services) and ISO 37001 certification (Anti-bribery management systems).

CDMO Services Released by Alfa Chemistry Offer New Possibilities for Pharmaceutical Development & Manufacturing

Known for its competence, responsibility, and innovative capability in chemical supply, Alfa Chemistry recently unveiled its new role as a CDMO service provider for pharmaceutical companies worldwide.

Celegence unveils next level efficiencies for eCTD compliance with new functionality added to Dossplorer™

New functionality added to advanced dossier management solution to bring greater efficiencies to eCTD compliance

PUROLITE'S NEW STATE-OF-THE-ART FACILITY MARKS INNOVATIVE BIOPROCESSING MANUFACTURING EXPANSION

A ribbon-cutting ceremony was held on Thursday, October 13 to celebrate the achievement of Purolite, an Ecolab company’s increased bioprocessing resin production to meet the growing demand for biopharmaceutical products globally.

Creative Peptides Rolls Out Ready-to-Ship Fmoc-Tyr(HP03Bzl)-OH Product from Small Quantity to Large Scale

Creative Peptides announces to provide ready-to-ship Fmoc-Tyr(HP03Bzl)-OH products with 90% and 95% purities, which can be ordered in small amounts or large scale according to client demand.